OSCR 주식 스냅샷 가격, 시가총액, P/E, EPS, ROE, 부채/자본, 52주 범위

03
가격 $30.94
P/E (TTM) 21.3
EPS (TTM) $1.45
매출 (TTM) $15.32B
ROE (TTM) 34.3%
부채/자본 (MRQ) 0.2
52주 범위 $11–$34

OSCR 주가 차트 기술 지표가 포함된 일일 OHLCV — 팬, 확대/축소 및 보기 사용자 정의

04
범위
막대

막대 세분성은 선택한 기간에 따라 조정됩니다. 막대의 시가/고가/저가/종가를 보려면 차트에 마우스를 올리세요.

Oscar Health, Inc. Class A Common Stock 정보 위키백과 회사 개요

05 · wikidata

Oscar Management Corporation, doing business as Oscar Health is an American for-profit health insurance company, founded in 2012 by Joshua Kushner, Kevin Nazemi and Mario Schlosser, and is headquartered in New York City. The company sells health insurance and additionally provides other services in the health insurance industry through telemedicine, healthcare focused technological interfaces, and transparent claims pricing systems.

History

2012–2015

According to the company, it was founded in 2012 by Mario Schlosser, Joshua Kushner, and Kevin Nazemi, who were classmates at Harvard Business School. Mother Jones reported in March 2020 that Kushner and his brother, Jared, owned the firm's parent company, Thrive Partners III, at the time of its incorporation in 2013. Oscar began selling insurance for 2013, the same year that the Affordable Care Act exchanges and individual mandate went into effect for the 2014 plan year. In its first year, Oscar secured 16,000 members. In 2015, Oscar expanded coverage to New Jersey and grew to about 40,000 members.

2016

Oscar had 145,000 members in New York, New Jersey, California, and Texas in 2016. The firm expanded its operations to Tempe, Arizona, in August that year, where it decided to locate its Concierge teams, their name for their member services model. On August 23, Oscar announced it would be exiting the New Jersey Marketplace at the end of 2016, citing uncertainties in the market that would make it challenging "to operate effectively and continue to deliver access to quality healthcare." Oscar also announced that it would halve the size of its provider network in New York amidst rising premiums in order to "gain more control over pricing and patient experience".

In November 2016, the firm opened the Oscar Center in partnership with Mount Sinai Health System. Located in Brooklyn Heights, next to the Jay Street–MetroTech station, the Oscar Center had a primary care practice only available to Oscar policyholders, with a doctor, nurse practitioner, and a behavioral health specialist. It also hosted free classes for members, such as yoga classes or classes for expectant mothers. On March 13, 2020, Oscar closed the Oscar Center "until further notice."

2017

On April 25, 2017, Oscar announced its entrance into the small group insurance market, offering health plans in New York. On June 15, 2017, Oscar announced its partnership with Cleveland Clinic to offer individual health insurance plans to consumers in five counties in Northeastern Ohio.

On June 21, 2017, Oscar announced its intention to expand to additional markets in 2018 in areas of Tennessee, Ohio, Texas, New Jersey and California. On July 12, 2017, Oscar announced that it would be selling small group insurance in the Nashville metro area to companies with up to 50 employees through a strategic partnership with Humana.

A report by the New York Times in October 2017 speculated that Oscar Health had ties to Saudi Arabia. That month, Jared and Joshua Kushner visited Saudi Arabia's Crown Prince Mohammed bin Salman within days of each other. Despite Jared severing ties with Thrive Partners when he began working for the Trump administration, these coordinated visits raised questions about his ability to be impartial on Saudi affairs. Five months after Kushner's visit to Saudi Arabia in October 2017, Oscar Health announced a $165 million round of financing.

While a spokesman for Kushner said that Oscar Health's management didn't know of direct investment by the Saudis, he declined to disclose if Saudis had invested in Thrive funds. He only confirmed that Thrive hadn't received money from any Saudi parties since the presidential election. In May 2018, Jared Kushner disclosed $8.2 million in capital gains from Thrive funds.

2020–present

In January 2020, Oscar announced a partnership with Cigna to bring health insurance plans to small businesses. The partnership, Cigna + Oscar, will "launch in select markets in 2020 and plan to expand the partnership over time."

As of June 2020, Oscar had sold individual health insurance plans, both directly and through health insurance marketplaces, in New York, Texas and California. Oscar sells Medicare Advantage plans in New York City and Houston, Texas. Mario Schlosser is the company's CEO, after serving as Co-CEO with Nazemi until the latter's departure in early 2015. While Kushner does not hold a formal role in Oscar's daily operations, he remains a major shareholder and Schlosser confirmed (as of 2017) that he has "significant input in multiple aspects of the company like strategy, hiring, and marketing."

Oscar Health raised $1.2 billion on March 3, 2021, after an IPO.

Oscar Health reported 1.1 million members across its platform, which equates to 1 in 13 ACA exchange-based enrollees. The company announced it would exit the Arkansas and Colorado markets for plan year 2023.

Mario Schlosser steps down as CEO on April 3, 2023, transitioning to President of Technology. Mark Bertolini takes over as CEO.

In 2025, Oscar Health was ranked 437th by revenue on the Fortune 500 list and 42nd within the healthcare sector in the same rankings.

Marketing and brand

Oscar Health has run marketing campaigns on the New York City Subway. Bloomberg News reported the advertising campaigns feature cartoons suggesting "an easier way of getting medical care." AdWeek described Oscar Health's print ads as featuring "whimsical, animated characters".

In 2015, AdWeek reported that Oscar was airing its first television campaign targeted at the demographics of "new parents who are too frazzled to shop for health insurance." The ad launched on network stations in New Jersey and New York areas, cable, movie theaters located in New Jersey and in advertising within the Spotify app.

In 2016, Oscar ran a subway ad campaign with an educational bent around what the problems are with the American healthcare system.

Finances

Funding

Oscar has raised capital through a series of funding rounds. Its investors include Thrive Capital, General Catalyst Partners, Khosla Ventures, CapitalG, and Fidelity Investments.

During the May 2014 Series A round, Peter Thiel's Founders Fund led the series investing $30 million. By the close of Series A, Forbes reported the valuation of the company at $800 million.

During the 2015 Series B round, Oscar Health raised $145 million, bringing the total capital raised to $300 million, thus valuing the company at $1.5 billion. Series B investors included Formation 8, Horizons Ventures, Wellington Management Company, and Goldman Sachs.

In September 2015, Oscar announced a funding round with Google Ventures and Google Capital, valuing the company at $1.75 billion.

During the 2016 Series C round, Oscar raised $400 million led by Fidelity Investments, with secondary participation from previous investors, with a reported valuation of $2.7 billion. In 2018, Alphabet invested $375 million in Oscar Health. As of 2019, the company had raised $1.3 billion, and was valued at $3.2 billion.

In June 2020, Oscar raised $225 million in funding, in which the funding round saw participation from previous investors and also new investors, namely Baillie Gifford and Coatue.

Revenue

In 2014, New York magazine reported that as of May 2014, Oscar Health had 16,000 subscribers enrolled in its insurance program producing an estimated $72 million. In 2015, Forbes reported that Oscar Health had 40,000 subscribers with an average subscriber paying annual fees of $4,500, placing Oscar Health's revenue estimates at $180 million.

Vox reported that in 2015, Oscar Health lost $92.4 million in New York as the firm's analytical models failed to accurately forecast "the people who signed up for coverage were sicker than the company had expected."

By 2016, Oscar Health had 135,000 subscribers, with roughly half residing in New York State.

In February 2017, Bloomberg reported that Oscar had lost $204.9 million in 2016.

In May 2017, Bloomberg reported that Oscar's first quarter loss had narrowed by nearly half, writing that the company was "beginning to get a handle on its medical costs." In August 2017, Bloomberg also reported that Oscar had posted a $57.6 million loss in the first half of 2017, down from the $83 million lost posted the year prior.

In December 2017, TechCrunch reported that Oscar would expect to generate $1 billion in revenue and enroll 250,000 in 2018.

In January 2020, TechCrunch reported that Oscar served 400,000 members and expected to bring in $2 billion by the end of the year.

Headquarters and offices

Oscar's headquarters are located in Tribeca, New York City. They also have a technology outpost in Los Angeles and a member services operation in Tempe, Arizona.

출처: 위키백과 (영어), CC BY-SA 4.0 · 위키백과에서 보기 ↗

Wikidata ↗

섹터Financials 산업Insurance 직원2,305 국가US

10년 성과 매출, 순이익, 마진 및 EPS 추세

06
매출$11.70B
2019-12-31 → 2025-12-31
EPS$-1.69
2019-12-31 → 2025-12-31
잉여현금흐름$1.06B
2021-12-31 → 2025-12-31
순이익률3.6%
2021-12-31 → 2025-12-31
가치 평가 및 비율 07–12

가치 평가 P/E, P/S, P/B, EV/EBITDA 비율 — 주식이 비싼가요, 싼가요?

지표 5년 추세 OSCR 5년 평균 동종업계 중앙값 결론
P/E (TTM) 21.35년 평균 ≈23.0 ≈23.0 15.4 고평가

동종 기업 중앙값은 지표별로 표준화된 기준으로 계산되며, 이 주식에 표시된 TTM/MRQ 기준과 항상 일치하지 않을 수 있습니다.

가치 · ≈ 5년 평균 · 산업 중앙값 · 중앙값 대비 평가

실적 기록 EPS 실제 vs 예상, 서프라이즈 %, 달성률, 다음 실적 발표일

14
평균 서프라이즈 24.3%
다음 실적 11월 04, 2026
기간보고서EPS ActualEPS 예상서프라이즈
2026년 6월 30일 8월 6, 2026 $1.10 $0.39 179.5%
2026년 3월 31일 $2.07 $1.21 71.5%
2025년 12월 31일 $-1.24 $-0.91 -37.0%
2025년 9월 30일 $-0.53 $-0.57 6.6%
2025년 6월 30일 $-0.89 $-0.47 -88.5%
2025년 3월 31일 $0.92 $0.81 13.8%

전체 기본 지표 연도별 모든 지표 — 손익계산서, 대차대조표, 현금흐름

15
손익계산서 13
지표 추세 202520242023202220212020
Revenue $11.70B$9.18B$5.86B$3.96B$1.84B$463M
SG&A Expense $2.05B$1.76B$1.43B$1.26B$265M$167M
Operating Income $-396M$57M$-236M$-590M$-544M$-402M
Interest Expense ··$25M$23M$5M$4M
Other Non-op $-23M$-105.0K$-7M$2M$-1M·
Pretax Income $-437M$33M$-267M$-610M$-571M$-406M
Income Tax $6M$7M$3M$-523.0K$846.0K$1M
Net Income $-443M$25M$-271M$-606M$-573M$-407M
EPS (Basic) $-1.69$0.11$-1.22$-2.85$-3.20$-14.16
EPS (Diluted) $-1.69$0.10$-1.22$-2.85$-3.20$-14.16
Shares (Basic) 262,388,000240,386,000221,655,000212,475,000178,967,05629,263,424
Shares (Diluted) 262,388,000265,853,000221,655,000212,475,000178,967,05629,263,424
EBITDA $-367M$89M$-205M·$-530M·
대차대조표 23
지표 추세 202520242023202220212020
Cash & Equivalents $2.77B$1.53B$1.87B$1.56B$1.10B$826M
Short-term Investments ·$624M$690M···
Receivables $363M·····
Other Current Assets $24M$21M$7M$6M$4M·
Current Assets $4.61B$2.85B$3.06B$4.12B$2.31B$1.87B
PP&E (Net) $88M$67M$62M$60M$47M$36M
PP&E (Gross) $230M$181M$150M$117M$89M$63M
Accum. Depreciation $142M$114M$88M$57M$42M$27M
Other Non-current Assets $120M$82M$83M$95M$97M$13M
Total Assets $6.33B$4.84B$3.60B$4.53B$3.32B$2.27B
Accounts Payable $507M$432M$273M$298M$235M$138M
Current Liabilities $4.86B$3.46B$2.43B$3.26B$1.85B$1.67B
Capital Leases $52M$61M$67M$72M$77M·
Other Non-current Liabilities $52M$61M$68M$72M$77M$0
Total Liabilities $5.34B$3.82B$2.80B$3.63B$1.93B$1.82B
Total Debt $430M$300M$299M·$0·
Common Stock ·····$2.0K
Paid-in Capital $4.26B$3.87B$3.68B$3.51B$3.39B$133M
Retained Earnings $-3.29B$-2.85B$-2.88B$-2.61B$-2.00B$-1.43B
Treasury Stock $3M$3M$3M$3M$3M$3M
AOCI $18M$-2M$1M$-10M$-4M$879.0K
Stockholders' Equity $978M$1.01B$804M$890M$1.39B$-1.30B
Liabilities + Equity $6.33B$4.84B$3.60B$4.53B$3.32B$2.27B
현금 흐름 16
지표 추세 202520242023202220212020
D&A $29M$32M$31M$15M$15M$11M
Stock-based Comp $88M$110M$160M$112M$86M$36M
Deferred Tax $2M$-2M$58.0K$-165.0K$-101.0K$-67.0K
Other Non-cash $1.42B$813M$-192M·$290M·
Operating Cash Flow $1.09B$978M$-272M$380M$-182M$223M
CapEx $36M$28M$26M$29M$26M$14M
Investing Cash Flow $-241M$-1.39B$577M$-227M$-775M$-345M
Debt Issued $410M$0$0$305M$0$147M
Net Debt Issued $410M$0$0···
Stock Repurchased ····$0$0
Net Stock Activity ····$0·
Financing Cash Flow $399M$68M$6M$301M$1.24B$612M
Net Change in Cash $1.25B$-341M$311M$455M$282M$490M
Taxes Paid $18M$674.0K$2M$2M$697.0K$2M
Free Cash Flow $1.06B$950M$-298M·$-208M·
Levered FCF ··$-323M·$-212M·
수익성 7
지표 추세 202520242023202220212020
Operating Margin -3.4%0.62%-4.0%·-29.6%·
Net Margin -3.8%0.28%-4.6%·-31.1%·
Pretax Margin -3.7%0.36%-4.6%·-31.0%·
EBITDA Margin -3.1%0.97%-3.5%·-28.8%·
ROA -7.9%0.60%-6.7%·-20.5%·
ROE -44.5%2.8%-32.0%·-36.7%·
ROIC -28.5%3.4%-21.6%·-39.3%·
유동성 및 지급능력 5
지표 추세 202520242023202220212020
Current Ratio 0.90.81.3·1.2·
Quick Ratio 0.60.60.8·0.6·
Debt / Equity 0.40.30.4·0.0·
LT Debt / Equity 0.40.30.4·0.0·
Interest Coverage ··-9.6·-115.4·
효율성 1
지표 추세 202520242023202220212020
Asset Turnover 2.12.21.4·0.7·
주당 3
지표 추세 202520242023202220212020
Revenue / Share $44.60$34.52$26.45·$10.27·
Cash Flow / Share $4.17$3.68$-1.23·$-1.02·
EPS (TTM) $-1.69$0.10$-1.22$-2.85$-3.20·
성장률 3
지표 추세 202520242023202220212020
Revenue YoY 27.5%56.5%47.9%115.6%297.3%·
Revenue CAGR 3Y 43.5%70.9%133.1%···
Revenue CAGR 5Y 90.8%·····
가치 평가 (TTM) 4
지표 추세 202520242023202220212020
Revenue TTM $11.70B$9.18B$5.86B$3.96B$1.84B·
Net Income TTM $-443M$25M$-271M$-606M$-573M·
P/E -8.5134.4-7.5-0.9-2.5·
Earnings Yield -11.8%0.74%-13.3%-115.9%-40.8%·

최신 기간은 왼쪽에 · null 값은 ·로 표시

재무제표 손익계산서, 대차대조표, 현금흐름 — 연간, 지난 5년

16
지표 2025-12-312024-12-312023-12-312022-12-312021-12-31
매출 $11.70B $9.18B $5.86B $3.96B $1.84B
영업이익률 % -3.4% 0.62% -4.0% · -29.6%
순이익 $-443M $25M $-271M $-606M $-573M
희석 EPS $-1.69 $0.10 $-1.22 $-2.85 $-3.20

기관 투자자 (13F) 459개의 제출자 · $6.2B 전체 · 기준일 2026년 9월 30일

17

분기별 SEC 양식 13F에서 이 주식을 보유하고 있다고 보고하는 기관. 롱 포지션만 해당하며, 단일 제출자는 별도의 옵션 레그에 대해 두 번 나타날 수 있습니다. 대규모 상쇄 풋/콜 포지션은 일반적으로 방향성에 대한 확신보다는 시장 조성 또는 헤지된 재고를 반영합니다.

보유자 459
보유 가치 $6.2B
신규 포지션 125
청산 포지션 46
기관 활동 — Q2 2026 대 이전 분기
신규 포지션 청산 포지션 증가함 감소 순주식 변동
125 (+51 이전 분기 대비) 46 (-18 이전 분기 대비) 147 (+22 이전 분기 대비) 115 (+3 이전 분기 대비) +22.8M

Q1 2026 대비 비교. SEC 양식 13F 제출은 분기 말로부터 45일 이내에 마감되며, 지연 제출자를 위한 짧은 유예 기간이 추가됩니다. 해당 기간 내에 있는 분기는 가장 최근에 완전히 보고된 쌍을 선호하여 건너뜁니다.

기관 가치 주식 % 추적된 13F 중 유형
BlackRock, Inc. $587,153,449 20,587,428 9.50% 주식
D. E. Shaw & Co., Inc. $360,595,957 12,643,617 5.84% 주식
VANGUARD PORTFOLIO MANAGEMENT LLC $314,559,172 11,029,424 5.09% 주식
VANGUARD CAPITAL MANAGEMENT LLC $301,725,543 10,579,437 4.88% 주식
VANGUARD GROUP INC $297,476,962 20,701,250 4.82% 주식
AMERICAN CENTURY COMPANIES INC $258,255,502 9,055,242 4.18% 주식
JANE STREET GROUP, LLC $181,530,912 6,365,039 2.94% 주식
Thrive Capital Management, LLC $180,919,957 6,343,617 2.93% 주식
GEODE CAPITAL MANAGEMENT, LLC $165,994,311 5,819,186 2.69% 주식
STATE STREET CORP $165,454,531 5,801,351 2.68% 주식
SUSQUEHANNA INTERNATIONAL GROUP, LLP $162,917,648 5,712,400 2.64% 콜 옵션
FMR LLC $142,557,861 4,998,523 2.31% 주식
CITADEL ADVISORS LLC $120,626,823 4,229,552 1.95% 주식
TWO SIGMA INVESTMENTS, LP $115,097,850 4,035,689 1.86% 주식
DIMENSIONAL FUND ADVISORS LP $101,885,043 3,571,731 1.65% 주식
BIT Capital GmbH $97,480,134 3,417,957 1.58% 주식
RENAISSANCE TECHNOLOGIES LLC $93,673,940 3,284,500 1.52% 주식
JACOBS LEVY EQUITY MANAGEMENT, INC $86,282,012 3,025,316 1.40% 주식
GLYNN CAPITAL MANAGEMENT LLC $73,462,615 2,575,828 1.19% 주식
CITADEL ADVISORS LLC $72,469,320 2,541,000 1.17% 콜 옵션
GOLDMAN SACHS GROUP INC $65,298,165 2,289,557 1.06% 주식
NORTHERN TRUST CORP $63,063,680 2,211,209 1.02% 주식
WOLVERINE ASSET MANAGEMENT LLC $61,825,656 2,167,800 1.00% 풋 옵션
CHARLES SCHWAB INVESTMENT MANAGEMENT INC $60,458,493 2,119,863 0.98% 주식
MORGAN STANLEY $60,299,272 2,114,280 0.98% 주식
SUSQUEHANNA INTERNATIONAL GROUP, LLP $55,351,616 1,940,800 0.90% 풋 옵션
JANE STREET GROUP, LLC $53,968,396 1,892,300 0.87% 콜 옵션
Nuveen, LLC $50,501,648 1,770,745 0.82% 주식
BlackBarn Capital Partners LP $49,910,000 1,750,000 0.81% 풋 옵션
BNP PARIBAS FINANCIAL MARKETS $48,660,710 1,706,196 0.79% 주식
VANGUARD FIDUCIARY TRUST CO $45,996,029 1,612,764 0.74% 주식
CITADEL ADVISORS LLC $44,459,828 1,558,900 0.72% 풋 옵션
STATE OF MICHIGAN RETIREMENT SYSTEM $41,354,000 1,450,000 0.67% 주식
BANK OF AMERICA CORP /DE/ $37,594,294 1,318,173 0.61% 주식
Assenagon Asset Management S.A. $35,592,732 1,247,992 0.58% 주식
TWO SIGMA ADVISERS, LP $35,534,136 2,472,800 0.58% 주식
UBS Group AG $34,596,357 1,213,056 0.56% 주식
JANE STREET GROUP, LLC $33,796,200 1,185,000 0.55% 풋 옵션
GROUP ONE TRADING LLC $32,744,154 1,148,112 0.53% 주식
HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND $31,200,652 1,093,992 0.51% 주식
Qube Research & Technologies Ltd $30,913,940 1,083,939 0.50% 주식
TUDOR INVESTMENT CORP ET AL $29,055,948 1,018,792 0.47% 주식
GILDER GAGNON HOWE & CO LLC $28,576,515 1,001,982 0.46% 주식
JPMORGAN CHASE & CO $26,387,407 885,558 0.43% 주식
FEDERATED HERMES, INC. $26,096,200 915,014 0.42% 주식
WELLS FARGO & COMPANY/MN $23,408,907 820,789 0.38% 주식
Walleye Capital LLC $23,243,058 814,974 0.38% 주식
Point72 Asset Management, L.P. $22,809,212 799,762 0.37% 주식
Walleye Trading LLC $22,744,700 797,500 0.37% 콜 옵션
Bank of New York Mellon Corp $22,032,138 772,515 0.36% 주식

전체 459 기관 투자자 보기 →

행동주의자 및 5% 이상 소유자 2 보유

18

SEC 서류 13D를 제출한 투자자 — 발행인에 영향을 미치려는 의도로 5% 이상의 실질 소유권(행동주의 지분, 이사회 캠페인, M&A). 각 행은 해당 제출자의 포지션에 대한 가장 최근에 알려진 상태를 보여줍니다.

제출자 제출됨 지분 상태 목적 제출
Claremount TW, L.P., Claremount V Associates, L.P., Claremount VI Associates, L.P., Claremount VII Associates, L.P., Joshua Kushner, Thrive Capital Partners II, L.P., Thrive Capital Partners III, L.P., Thrive Capital Partners V, L.P., Thrive Capital Partners VI Growth, L.P., Thrive Capital Partners VII Growth, L.P., Thrive Partners II GP, LLC, Thrive Partners III GP, LLC, Thrive Partners V GP, LLC, Thrive Partners VI GP, LLC, Thrive Partners VII GP, LLC, Thrive Partners VII Growth GP, LLC 2026년 9월 18일 12.10% 수정본 · SEC
Thrive Capital Partners II, L.P. (2), Thrive Partners II GP, LLC (2), Thrive Capital Partners III, L.P. (2), Claremount TW, L.P. (2), Thrive Partners III GP, LLC (2), Thrive Capital Partners V, L.P. (2), Claremount V Associates, L.P. (2), Thrive Partners V GP, LLC (2), Thrive Capital Partners VI Growth, L.P. (2), Claremount VI Associates, L.P. (2), Thrive Partners VI GP, LLC (2), Thrive Capital Partners VII Growth, L.P. (2), Thrive Partners VII Growth GP, LLC (2), Claremount VII Associates, L.P. (2), Thrive Partners VII GP, LLC (2), Joshua Kushner (2) ×4 제출 서류 2024년 11월 13일 · 최초 제출 · SEC

Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.

회사 내부자 23 명의 내부자 · 12 임원 · 12 이사

19
내부자 역할 마지막 활동 보유 주식 수 매수 12개월 매도 12개월 순매수/매도 12개월
Mark T Bertolini Chief Executive Officer 2026년 6월 30일 S 7,751,570 1 8 $-58,759,399
Richard Scott Blackley Chief Financial Officer 2026년 9월 3일 S 1,046,108 0 9 $-7,941,907
Janet Liang President, Oscar Insurance 2026년 9월 3일 S 248,697 0 5 $-821,072
Steven Wolin Chief Operating Officer 2024년 12월 1일 M 102,598 0 0 $0
Meghan V. Joyce Chief Operating Officer 2022년 3월 1일 M 43,070 0 0 $0
Joshua Kushner Co-Founder and Vice Chairman 2026년 9월 18일 J 0 0 0 $0
Victoria Baltrus Chief Accounting Officer 2026년 9월 3일 S 213,631 0 5 $-194,480
Adam Mcananey Chief Legal Officer 2026년 9월 3일 S 209,004 0 5 $-783,513
Alessandrea C. Quane EVP, Chief Insurance Officer 2024년 12월 5일 M 430,216 0 0 $0
Ranmali Bopitiya EVP & Chief Legal Officer 2024년 12월 1일 M 241,488 0 0 $0
Dennis Weaver Chief Clinical Officer 2022년 12월 1일 M 27,110 0 0 $0
Joel Klein Chief Policy & Strat. Officer 2021년 8월 18일 M 17 0 0 $0
Vanessa Ames Wittman 이사 2026년 9월 18일 S 112,121 0 1 $-806,000
Mario Schlosser 이사 2026년 9월 3일 S 449,444 0 29 $-68,790,950
William Gassen 이사 2026년 7월 9일 A 82,840 0 0 $0
David Plouffe 이사 2026년 7월 9일 A 137,121 0 0 $0
Sid Sankaran 이사 2026년 7월 9일 A 22,609 0 0 $0
Laura W Lang 이사 2026년 6월 4일 A 82,840 0 0 $0
Jeffery H Boyd 이사 2026년 4월 9일 A 705,673 0 0 $0
Elbert O. Robinson Jr. 이사 2025년 5월 12일 S 64,512 0 0 $0
Jr Charles E Phillips 이사 2022년 10월 14일 A 85,787 0 0 $0
Teri List-Stoll 이사 2021년 3월 5일 A 50,000 0 0 $0
Ari Fischel · 2021년 3월 5일 A 0 0 0 $0

SEC 양식 3/4/5 제출 서류 기준 내부자; 순매수/매도는 공개 시장 거래만 해당

ETF 보유 현황 46 ETF 보유

20

가중치는 직접적인 주식 보유(N-PORT)만 반영합니다. 레버리지 또는 파생 상품 기반 펀드는 표시되지 않은 추가 스왑 노출을 보유할 수 있습니다.

펀드 비중 단위 기준일 출처
ABLS · Abacus FCF ETF Trust 5.83% 867 NS 2026년 7월 31일 N-PORT
PTH · Invesco Exchange-Traded Fund Trust 1.95% 188,213 SH 2026년 10월 2일 일간
RNIN · EA Series Trust 1.20% 70,047 NS 2026년 7월 31일 N-PORT
FYC · First Trust Exchange-Traded AlphaDE… 0.74% 307,696 NS 2026년 7월 31일 N-PORT
JSML · Janus Detroit Street Trust 0.60% 69,666 NS 2026년 7월 31일 N-PORT
IWO · iShares Trust 0.52% 2,269,828 SH 2026년 9월 11일 일간
JSMD · Janus Detroit Street Trust 0.51% 171,181 NS 2026년 7월 31일 N-PORT
VTWG · VANGUARD SCOTTSDALE FUNDS 0.40% 258,034 SH 2026년 8월 19일 일간
DWAS · Invesco Exchange-Traded Fund Trust … 0.36% 48,469 SH 2026년 10월 2일 일간
FYX · First Trust Exchange-Traded AlphaDE… 0.35% 152,933 NS 2026년 7월 31일 N-PORT
BKSE · BNY Mellon ETF Trust 0.31% 8,798 NS 2026년 7월 31일 N-PORT
BBSC · J.P. Morgan Exchange-Traded Fund Tr… 0.27% 61,099 NS 2026년 7월 31일 N-PORT
FYEE · Fidelity Greenwood Street Trust 0.27% 19,102 NS 2026년 7월 31일 N-PORT
IWM · iShares Trust 0.26% 6,175,602 SH 2026년 9월 11일 일간
FBUF · Fidelity Greenwood Street Trust 0.25% 1,889 NS 2026년 7월 31일 N-PORT
ISCG · iShares Trust 0.24% 71,367 SH 2026년 9월 11일 일간
RSSL · Global X Funds 0.24% 115,406 NS 2026년 7월 31일 N-PORT
VTWO · VANGUARD SCOTTSDALE FUNDS 0.21% 1,387,125 SH 2026년 8월 19일 일간
FHEQ · Fidelity Greenwood Street Trust 0.21% 61,010 NS 2026년 7월 31일 N-PORT
VBK · VANGUARD INDEX FUNDS 0.19% 3,171,535 SH 2026년 8월 19일 일간
DFAS · Dimensional ETF Trust 0.16% 805,292 NS 2026년 7월 31일 N-PORT
PRFZ · Invesco Exchange-Traded Fund Trust 0.16% 145,781 SH 2026년 10월 2일 일간
FAD · First Trust Exchange-Traded AlphaDE… 0.15% 27,872 NS 2026년 7월 31일 N-PORT
ESML · iShares Trust 0.11% 96,895 SH 2026년 9월 11일 일간
FNCL · FIDELITY COVINGTON TRUST 0.08% 61,975 NS 2026년 7월 31일 N-PORT
VB · VANGUARD INDEX FUNDS 0.08% 5,488,922 SH 2026년 8월 19일 일간
VFH · VANGUARD WORLD FUND 0.08% 384,466 SH 2026년 8월 19일 일간
WSML · iShares Trust 0.07% 14,630 SH 2026년 9월 11일 일간
VXF · VANGUARD INDEX FUNDS 0.07% 2,534,194 SH 2026년 8월 19일 일간
IUS · Invesco Exchange-Traded Self-Indexe… 0.04% 12,495 SH 2026년 10월 2일 일간
DFSU · Dimensional ETF Trust 0.03% 20,892 NS 2026년 7월 31일 N-PORT
DCOR · Dimensional ETF Trust 0.02% 21,472 NS 2026년 7월 31일 N-PORT
DFAC · Dimensional ETF Trust 0.02% 286,808 NS 2026년 7월 31일 N-PORT
TILT · FlexShares Trust 0.02% 12,166 NS 2026년 7월 31일 N-PORT
DFAU · Dimensional ETF Trust 0.01% 50,403 NS 2026년 7월 31일 N-PORT
IWV · iShares Trust 0.01% 64,590 SH 2026년 9월 11일 일간
VTI · VANGUARD INDEX FUNDS 0.01% 7,601,113 SH 2026년 8월 19일 일간
VT · VANGUARD INTERNATIONAL EQUITY INDEX… 0.01% 194,738 SH 2026년 8월 19일 일간
VTHR · VANGUARD SCOTTSDALE FUNDS 0.01% 19,808 SH 2026년 8월 19일 일간
DFUS · Dimensional ETF Trust 0.01% 66,708 NS 2026년 7월 31일 N-PORT
ESGV · VANGUARD WORLD FUND 0.01% 53,203 SH 2026년 8월 19일 일간
ITOT · iShares Trust 0.01% 287,602 SH 2026년 9월 11일 일간
DXUV · Dimensional ETF Trust 0.00% 472 NS 2026년 7월 31일 N-PORT
IAK · iShares Trust · 117,671 SH 2026년 9월 11일 일간
ISCB · iShares Trust · 10,063 SH 2026년 9월 11일 일간
SMLF · iShares Trust · 286,871 SH 2026년 9월 11일 일간

OSCR 분석가 합의 강세 및 약세 애널리스트 의견, 12개월 목표 주가, 상승 여력

21
평점 · 19 명의 애널리스트 매수
중앙값 목표 $33.50 +8.3%
2 10.5% 적극 매수
7 36.8% 매수
9 47.4% 보유
1 5.3% 매도
0 0.0% 적극 매도

12개월 목표 주가

10 명의 애널리스트 · 2026-10-03

평균 목표 $35.40 +14.4%

지금 현재가 $30.94
저가$26.00 평균$35.40 고가$49.00

동종 기업 비교(GICS 하위 산업) 주요 지표 대 섹터 동종 기업

22

회계연도 기준, 각 회사의 마지막 회계연도 말 종가 기준 가격입니다.

티커 시가총액 P/E 매출 YoY 순이익률 ROE 매출 총이익률
OSCR · -8.5 27.5% -3.8% -44.5% ·
AFL $57.20B 16.2 -9.3% 21.2% 12.9% ·
PRU · · · · · ·
PFG $19.18B 16.8 -3.1% 7.6% 10.3% ·
UNM · · · · · ·
GL $12.90B 9.9 3.7% 19.4% 20.4% ·
PRI $8.22B 11.3 6.6% 22.8% 31.9% ·
LNC $8.46B 7.6 -1.2% 6.5% 12.3% ·
CNO $4.01B 18.5 0.85% 5.1% 8.9% ·

최신 뉴스 이 회사 관련 최근 헤드라인

23

나의 지표 나만의 관심 목록 — 전체 기본 재무제표에서 선택한 항목

26

중요한 지표를 선택하세요. 상단의 전체 기본 정보에서 원하는 행 옆의 +를 클릭하세요.

선택 항목이 저장되어 모든 티커에서 유지됩니다.

출처: SEC 10-Q 제출 8월 7, 2026